Sun Young Choi

Dr. Sun Young Choi

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
KKKyung Ah Kim
Kyung Ah Kim
SCSun Young Choi
Sun Young Choi
RKRan Kim
Ran Kim
Kim KA, et al. Korean J Radiol. 2021 Jan;22:e11. https://doi.org/10.3348/kjr.2020.0675

1 June 2020 in BMC Cancer
Verified
Journal Article
Open access
PDF file
JNJoon Yeul Nam
Joon Yeul Nam
ACA Reum Choe
A Reum Choe
DSDong Hyun Sinn
Dong Hyun Sinn
HKHwi Young Kim
Hwi Young Kim
SYSu Jong Yu
Su Jong Yu
KYKwon Yoo
Kwon Yoo
Background: The decision of transarterial chemoembolization (TACE) initiation and/or repetition remains challenging in patients with unresectable hepatocellular carcinoma (HCC). The aim was to develop a prognostic scoring system to guide TACE initiation/repetition. Methods: A total of 597 consecutive patients who underwent TACE as their initial treatment for unresectable HCC were included. We derived a prediction model using independent risk factors for overall survival (OS), which was externally validated in an independent cohort (n = 739). Results: Independent risk factors of OS included Albumin-bilirubin (ALBI) grade, maximal tumor size, alpha-fetoprotein, and tumor response to initial TACE, which were used to develop a scoring system (“ASAR”). C-index values for OS were 0.733 (95% confidence interval [CI] = 0.570–0.871) in the derivation, 0.700 (95% CI = 0.445–0.905) in the internal validation, and 0.680 (95% CI = 0.652–0.707) in the external validation, respectively. Patients with ASAR< 4 showed significantly longer OS than patients with ASAR≥4 in all three datasets (all P < 0.001). Among Child-Pugh class B patients, a modified model without TACE response, i.e., “ASA(R)”, discriminated OS with a c-index of 0.788 (95% CI, 0.703–0.876) in the derivation, and 0.745 (95% CI, 0.646–0.862) in the internal validation, and 0.670 (95% CI, 0.605–0.725) in the external validation, respectively. Child-Pugh B patients with ASA(R) < 4 showed significantly longer OS than patients with ASA(R) ≥ 4 in all three datasets (all P < 0.001). Conclusions: ASAR provides refined prognostication for repetition of TACE in patients with unresectable HCC. For Child-Pugh class B patients, a modified model with baseline factors might guide TACE initiation.

27 June 2019 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
SLSu Hwan Lee
Su Hwan Lee
JLJin Hwa Lee
Jin Hwa Lee
JCJung Hyun Chang
Jung Hyun Chang
SKSoo Jung Kim
Soo Jung Kim
HYHee-Young Yoon
Hee-Young Yoon
YRYon Ju Ryu
Yon Ju Ryu
Although infections caused by nontuberculous mycobacteria (NTM) are increasing in prevalence, there are few data about hemoptysis in patients with NTM lung disease. This study investigated the characteristics and prognosis of hemoptysis secondary to NTM infection. Following a retrospective review of cases managed between 2006 and 2016, 183 patients with NTM lung disease were enrolled and analyzed. Among 183 patients with NTM lung disease, Mycobacterium intracellulare (n = 64, 35%) was the major cause of NTM infection, followed by M. avium (n = 59, 32.2%) and M. abscessus complex (n = 40, 21.9%). Hemoptysis developed in 78 patients (42.6%), among whom 33 (42.3%) required bronchial artery embolization (BAE). Between patients with and without hemoptysis, there were no significant differences with respect to sex, radiographic manifestations, distribution over 3 lobes on chest computed tomography, history of pulmonary tuberculosis, antiplatelet or anticoagulation therapy, and species of NTM. However, mean age at diagnosis was significantly lower in the hemoptysis group in univariate and multivariate analyses (65.7 ± 12.8 vs. 59.7 ± 11.8, P = 0.002, odds ratio: 0.969, 95% confidence interval: 0.944–0.996). Among patients with hemoptysis, those requiring medical therapy and those requiring BAE were not significantly different in terms of demographic characteristics, radiographic manifestations, and distribution over 3 lobes. All patients who received BAE showed immediate clinical improvement, no procedure-related complications, and none of them died during the period under review. NTM lung disease patients commonly experienced hemoptysis without specific risk factors except for relatively young age. Although some patients with hemoptysis needed BAE, the success rate of BAE was high, and there were no serious complications associated with BAE.

1 March 2019 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
KKKyung Ah Kim
Kyung Ah Kim
SCSun Young Choi
Sun Young Choi
MKMin Uk Kim
Min Uk Kim
SBSeung Yon Baek
Seung Yon Baek
SPSang Hui Park
Sang Hui Park
HKHwi Young Kim
Hwi Young Kim

1 August 2017 in Taiwanese Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
YKYoudong Kim
Youdong Kim
GJGyeong Sik Jeon
Gyeong Sik Jeon
SCSun Young Choi
Sun Young Choi
MKMan Deuk Kim
Man Deuk Kim
SLShin Jae Lee
Shin Jae Lee
To evaluate the efficacy and safety of sclerotherapy as the treatment of infected postoperative lymphocele in gynecologic malignancy patients. Percutaneous catheter drainage (PCD) with or without sclerotherapy was performed for postoperative lymphocele in 75 patients from 2002 to 2014. Eighty-eight lymphoceles (43 non-infected as group A, 45 infected as group B) in 75 patients (mean age ± SD; 50.3 ± 11.3) were included. Sclerotherapy was performed in 17 (39.5%, group A-S) lymphoceles in group A and 14 (31.1%, group B-S) in group B. Absolute ethanol was the most frequently used sclerosant (28 of total 36 sessions). Mean follow-up period was 37 months (range: 1-154). Sclerotherapy was clinically successful in 13 lymphoceles in both group A-S (76.5%) and group B-S (92.9%) without statistical significance. Compared to the pre-sclerotherapy period, group B-S demonstrated significantly decreased drainage volume after sclerotherapy (662.7 ml vs. 100.6 ml, p = 0.019). Group A-S failed to demonstrate significant decrease in drainage volume after sclerotherapy. Recurrence occurred in 4 patients in group A-S and 1 in group B-S, without statistical significance. No major complication was noted. Sclerotherapy significantly reduces the drainage volume, and might help shorten catheter placement time in infected lymphoceles.

6 January 2015 in Diagnostic and Interventional Radiology
Verified
Journal Article
Closed access
SCSun Young Choi
Sun Young Choi
BKByung Kook Kwak
Byung Kook Kwak
HSHyung Jin Shim
Hyung Jin Shim
JLJaehwi Lee
Jaehwi Lee
SHSoon Uk Hong
Soon Uk Hong
KKKyung Ah Kim
Kyung Ah Kim
Diagnostic and Interventional Radiology